MAPT and Alzheimer disease: The multifaceted pathology of AD—driven by interconnected mechanisms such as Aβ plaque accumulation,5 tau hyperphosphorylation,6 chronic neuroinflammation,7 mitochondrial dysfunction,8 synaptic dysfunction9 and neuronal loss—underscores the urgent need for novel therapeutic approaches capable of simultaneously addressing multiple pathological pathways.10